The Nano-Based Drug Delivery section of Frontiers in Medical Technology publishes pioneering research in the field of nanotechnology for drug delivery purposes. The section focuses on nanotechnology for therapeutic, diagnostic and theranostic applications, and, within this context, both theoretical and interpretative studies as well as applied research are welcome.
The Nano-Based Drug Delivery section of Frontiers in Medical Technology publishes pioneering research in the field of nanotechnology for drug delivery purposes. The section focuses on nanotechnology for therapeutic, diagnostic and theranostic applications, and, within this context, both theoretical and interpretative studies as well as applied research are welcome.
The overarching mission is to provide visibility for new nanomedicines for a broad range of therapeutic applications (cancer as well as other diseases). As such, the section offers the readers an invaluable collection of thorough studies reporting the design, characterisation, in vitro and in vivo outcomes of nanomedicine-based drug delivery systems.
The aim is to support the continuous development of nanomedicines and expand the number of their applications. Topics of interest include, but are not limited to: nanoparticles, liposomes, micelles, nanoemulsions, polymer-protein/drug conjugates, dendrimers, nanocrystals, polymeric vesicles, antibody-drug conjugates, nanogels, nanotubes, etc. Furthermore, the investigation of the new drug delivery platforms alone, without a drug, and their interaction with biological systems is of interest.
It is important to highlight that a thorough characterization of such delivery systems is key to push forward the know-how in this research area, and, as such, it is a mandatory requirement for all the outputs published within this section.
Indexed in: Google Scholar, DOAJ, CrossRef, CLOCKSS
PMCID: NA
Nano-Based Drug Delivery welcomes submissions of the following article types: Brief Research Report, Case Report, Classification, Clinical Trial, Community Case Study, Correction, Curriculum, Instruction, and Pedagogy, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Nano-Based Drug Delivery, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact medicaltechnology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact medicaltechnology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org